<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To describe and analyse the clinical and immunological characteristics of a large series of patients with delayed <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A cross-sectional study was carried out </plain></SENT>
<SENT sid="2" pm="."><plain>Patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) who developed renal involvement &gt;or=5 years after the first manifestation(s) of the disease (delayed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>, n = 48) were compared with patients with SLE in whom <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> developed within 5 years or less after SLE appeared (early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e>, n = 187) </plain></SENT>
<SENT sid="3" pm="."><plain>A control group, the no <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> (NLN) group, comprised patients with longstanding SLE (duration of disease &gt;10 years) who had never shown signs of renal involvement (n = 164) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The group with delayed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> was positively associated with <z:e sem="disease" ids="C1527336" disease_type="Disease or Syndrome" abbrv="">Sj√∂gren's syndrome</z:e>, lung involvement and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> as compared with early <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>However, its renal clinical expression and histopathological patterns were similar to those of early-<z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The frequency of anti-dsDNA, anti-Sm and anti-RNP antibodies was higher in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> than in the NLN group, as was the frequency of low complement levels </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0152084" disease_type="Disease or Syndrome" abbrv="">Jaccoud</z:e>'s <z:hpo ids='HP_0003040'>arthropathy</z:hpo> was a protective factor for <z:hpo ids='HP_0000123'>nephritis</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Delayed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LN</z:e> is not uncommon in patients with SLE </plain></SENT>
<SENT sid="9" pm="."><plain>The identified risk factors might aid in its diagnosis and enhance the ability to identify patients at risk for this complication of SLE </plain></SENT>
</text></document>